Literature DB >> 24803551

Inhibitory effect of adenosine on intimal hyperplasia and proliferation of smooth muscle cells in a carotid arterial anastomosis animal model.

Gokhan Albayrak1, Erdem Silistreli2, Bekir Ergur3, Sule Kalkan4, Ozalp Karabay2, A Cenk Erdal2, Unal Acikel5.   

Abstract

PURPOSE: The effect of adenosine (9-β-0-ribifuranosyladenine) on the endothelial cell proliferation and neointimal hyperplasia is investigated in the rabbit carotid artery anastomosis model.
METHODS: Twenty-eight New Zealand white rabbits were arranged in four groups of seven animals each. The right carotid arteries of each animal were transsected and re-anastomosed. The left sides remained as control. In Group A, no medication was used. In Group B, subcutaneous Adenosine was applied for 3 days. In Group C, the same dose was applied for 7 days, and in Group D for 21 days. After 28 days, the luminal diameters, luminal areas, intima/media ratios were all measured by using histopathological evaluation.
FINDINGS: The mean luminal diameters and areas of the four groups were smaller than the control ones. Massive thickening of smooth muscle cell proliferation and dense intensifying in the connecting tissues were observed most prominently in Group A, in decreasing degrees within other groups. Intima/media ratio was highest in Group A. Scoring the quantity of e-NOS positive staining also revealed a significant difference between the experimental groups and their control associates.
CONCLUSION: The process of endothelial cell proliferation and neointimal hyperplasia can be significantly reduced by the use of adenosine.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Adenosine; endothelial cell proliferation; neointimal hyperplasia; vasculary anastomosis

Mesh:

Substances:

Year:  2014        PMID: 24803551     DOI: 10.1177/1708538114533962

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  4 in total

1.  Study on the Active Constituents and Molecular Mechanism of Zhishi Xiebai Guizhi Decoction in the Treatment of CHD Based on UPLC-UESI-Q Exactive Focus, Gene Expression Profiling, Network Pharmacology, and Experimental Validation.

Authors:  Yuan Liu; Xu He; Zhibiao Di; Xia Du
Journal:  ACS Omega       Date:  2022-01-28

2.  Lifelong impact of ENPP1 Deficiency and the early onset form of ABCC6 Deficiency from patient or caregiver perspective.

Authors:  Christine O'Brien; Gus Khursigara; Pedro Huertas; Beth Leiro; Liz Molloy; Catherine Nester
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

3.  ENPP1-Fc prevents neointima formation in generalized arterial calcification of infancy through the generation of AMP.

Authors:  Yvonne Nitschke; Yan Yan; Insa Buers; Kristina Kintziger; Kim Askew; Frank Rutsch
Journal:  Exp Mol Med       Date:  2018-10-29       Impact factor: 8.718

4.  Ectopic Calcification and Hypophosphatemic Rickets: Natural History of ENPP1 and ABCC6 Deficiencies.

Authors:  Carlos R Ferreira; Kristina Kintzinger; Mary E Hackbarth; Ulrike Botschen; Yvonne Nitschke; M Zulf Mughal; Genevieve Baujat; Dirk Schnabel; Eric Yuen; William A Gahl; Rachel I Gafni; Qing Liu; Pedro Huertas; Gus Khursigara; Frank Rutsch
Journal:  J Bone Miner Res       Date:  2021-08-16       Impact factor: 6.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.